Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
Phase 2
Withdrawn
- Conditions
- Cervical Intraepithelial Neoplasia
- Interventions
- Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment
- First Posted Date
- 2017-05-08
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- DFB Soria, LLC
- Registration Number
- NCT03143491
Study of SOR007 Ointment for Actinic Keratosis
Phase 2
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SOR007 (Uncoated Nanoparticulate Paclitaxel) OintmentOther: SOR007 Ointment Vehicle
- First Posted Date
- 2017-03-20
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- DFB Soria, LLC
- Target Recruit Count
- 33
- Registration Number
- NCT03083470
- Locations
- 🇺🇸
Moore Clinical Research, Tampa, Florida, United States
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
Phase 1
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: SOR007 Ointment 2.0%Drug: SOR007 Ointment 1.0%Drug: SOR007 Ointment 0.3%Drug: SOR007 Ointment 0.15%Drug: SOR007 Ointment Placebo
- First Posted Date
- 2016-12-28
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- DFB Soria, LLC
- Target Recruit Count
- 13
- Registration Number
- NCT03004339
- Locations
- 🇺🇸
DermResearch, Inc., Austin, Texas, United States
🇺🇸J&S Studies, Inc., College Station, Texas, United States
News
No news found